Literature DB >> 24953902

Cold hypersensitivity increases with age in mice with sickle cell disease.

Katherine J Zappia1, Sheldon R Garrison, Cheryl A Hillery, Cheryl L Stucky.   

Abstract

Sickle cell disease (SCD) is associated with acute vaso-occlusive crises that trigger painful episodes and frequently involves ongoing, chronic pain. In addition, both humans and mice with SCD experience heightened cold sensitivity. However, studies have not addressed the mechanism(s) underlying the cold sensitization or its progression with age. Here we measured thermotaxis behavior in young and aged mice with severe SCD. Sickle mice had a marked increase in cold sensitivity measured by a cold preference test. Furthermore, cold hypersensitivity worsened with advanced age. We assessed whether enhanced peripheral input contributes to the chronic cold pain behavior by recording from C fibers, many of which are cold sensitive, in skin-nerve preparations. We observed that C fibers from sickle mice displayed a shift to warmer (more sensitive) cold detection thresholds. To address mechanisms underlying the cold sensitization in primary afferent neurons, we quantified mRNA expression levels for ion channels thought to be involved in cold detection. These included the transient receptor potential melastatin 8 (Trpm8) and transient receptor potential ankyrin 1 (Trpa1) channels, as well as the 2-pore domain potassium channels, TREK-1 (Kcnk2), TREK-2 (Kcnk10), and TRAAK (Kcnk4). Surprisingly, transcript expression levels of all of these channels were comparable between sickle and control mice. We further examined transcript expression of 83 additional pain-related genes, and found increased mRNA levels for endothelin 1 and tachykinin receptor 1. These factors may contribute to hypersensitivity in sickle mice at both the afferent and behavioral levels.
Copyright © 2014 International Association for the Study of Pain. Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Aging; C fiber; Endothelin 1; KCNK; TRPA1; TRPM8

Mesh:

Substances:

Year:  2014        PMID: 24953902      PMCID: PMC4250326          DOI: 10.1016/j.pain.2014.05.030

Source DB:  PubMed          Journal:  Pain        ISSN: 0304-3959            Impact factor:   6.961


  59 in total

1.  Identification of a cold receptor reveals a general role for TRP channels in thermosensation.

Authors:  David D McKemy; Werner M Neuhausser; David Julius
Journal:  Nature       Date:  2002-02-10       Impact factor: 49.962

2.  Transgenic knockout mice with exclusively human sickle hemoglobin and sickle cell disease.

Authors:  C Pászty; C M Brion; E Manci; H E Witkowska; M E Stevens; N Mohandas; E M Rubin
Journal:  Science       Date:  1997-10-31       Impact factor: 47.728

3.  The mechano-activated K+ channels TRAAK and TREK-1 control both warm and cold perception.

Authors:  Jacques Noël; Katharina Zimmermann; Jérome Busserolles; Emanuel Deval; Abdelkrim Alloui; Sylvie Diochot; Nicolas Guy; Marc Borsotto; Peter Reeh; Alain Eschalier; Michel Lazdunski
Journal:  EMBO J       Date:  2009-03-12       Impact factor: 11.598

4.  TRPM8, but not TRPA1, is required for neural and behavioral responses to acute noxious cold temperatures and cold-mimetics in vivo.

Authors:  Wendy M Knowlton; Amber Bifolck-Fisher; Diana M Bautista; David D McKemy
Journal:  Pain       Date:  2010-06-12       Impact factor: 6.961

5.  Sexual dimorphism in endothelin-1 induced mechanical hyperalgesia in the rat.

Authors:  Elizabeth K Joseph; Jon D Levine
Journal:  Exp Neurol       Date:  2011-12-03       Impact factor: 5.330

6.  Pain-related behaviors and neurochemical alterations in mice expressing sickle hemoglobin: modulation by cannabinoids.

Authors:  Divyanshoo R Kohli; Yunfang Li; Sergey G Khasabov; Pankaj Gupta; Lois J Kehl; Marna E Ericson; Julia Nguyen; Vinita Gupta; Robert P Hebbel; Donald A Simone; Kalpna Gupta
Journal:  Blood       Date:  2010-03-19       Impact factor: 22.113

7.  The involvement of the transient receptor potential A1 (TRPA1) in the maintenance of mechanical and cold hyperalgesia in persistent inflammation.

Authors:  Diogo Santos M da Costa; Flavia Carla Meotti; Edinéia Lemos Andrade; Paulo César Leal; Emerson Marcelo Motta; João B Calixto
Journal:  Pain       Date:  2009-12-28       Impact factor: 6.961

8.  Serum levels of substance P are elevated in patients with sickle cell disease and increase further during vaso-occlusive crisis.

Authors:  L A Michaels; K Ohene-Frempong; H Zhao; S D Douglas
Journal:  Blood       Date:  1998-11-01       Impact factor: 22.113

9.  Vascular endothelial cells mediate mechanical stimulation-induced enhancement of endothelin hyperalgesia via activation of P2X2/3 receptors on nociceptors.

Authors:  Elizabeth K Joseph; Paul G Green; Oliver Bogen; Pedro Alvarez; Jon D Levine
Journal:  J Neurosci       Date:  2013-02-13       Impact factor: 6.167

Review 10.  Endothelin receptors and pain.

Authors:  Alla Khodorova; Jean-Pierre Montmayeur; Gary Strichartz
Journal:  J Pain       Date:  2009-01       Impact factor: 5.820

View more
  31 in total

Review 1.  Neuronal transient receptor potential (TRP) channels and noxious sensory detection in sickle cell disease.

Authors:  Katelyn E Sadler; Cheryl L Stucky
Journal:  Neurosci Lett       Date:  2018-11-30       Impact factor: 3.046

Review 2.  Targeting novel mechanisms of pain in sickle cell disease.

Authors:  Huy Tran; Mihir Gupta; Kalpna Gupta
Journal:  Blood       Date:  2017-11-30       Impact factor: 22.113

Review 3.  Early insights into the neurobiology of pain in sickle cell disease: A systematic review of the literature.

Authors:  Amanda M Brandow; Rebecca A Farley; Julie A Panepinto
Journal:  Pediatr Blood Cancer       Date:  2015-05-13       Impact factor: 3.167

4.  Safety and Utility of Quantitative Sensory Testing among Adults with Sickle Cell Disease: Indicators of Neuropathic Pain?

Authors:  Miriam O Ezenwa; Robert E Molokie; Zaijie Jim Wang; Yingwei Yao; Marie L Suarez; Cherese Pullum; Judith M Schlaeger; Roger B Fillingim; Diana J Wilkie
Journal:  Pain Pract       Date:  2015-01-12       Impact factor: 3.183

5.  Chronic Opioid Therapy and Central Sensitization in Sickle Cell Disease.

Authors:  C Patrick Carroll; Sophie Lanzkron; Carlton Haywood; Kasey Kiley; Megan Pejsa; Gyasi Moscou-Jackson; Jennifer A Haythornthwaite; Claudia M Campbell
Journal:  Am J Prev Med       Date:  2016-07       Impact factor: 5.043

Review 6.  Targeting novel mechanisms of pain in sickle cell disease.

Authors:  Huy Tran; Mihir Gupta; Kalpna Gupta
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2017-12-08

Review 7.  Regulation of Pain and Itch by TRP Channels.

Authors:  Carlene Moore; Rupali Gupta; Sven-Eric Jordt; Yong Chen; Wolfgang B Liedtke
Journal:  Neurosci Bull       Date:  2017-12-27       Impact factor: 5.203

8.  Substance P is increased in patients with sickle cell disease and associated with haemolysis and hydroxycarbamide use.

Authors:  Amanda M Brandow; Nancy J Wandersee; Mahua Dasgupta; Raymond G Hoffmann; Cheryl A Hillery; Cheryl L Stucky; Julie A Panepinto
Journal:  Br J Haematol       Date:  2016-08-19       Impact factor: 6.998

9.  End points for sickle cell disease clinical trials: patient-reported outcomes, pain, and the brain.

Authors:  Ann T Farrell; Julie Panepinto; C Patrick Carroll; Deepika S Darbari; Ankit A Desai; Allison A King; Robert J Adams; Tabitha D Barber; Amanda M Brandow; Michael R DeBaun; Manus J Donahue; Kalpna Gupta; Jane S Hankins; Michelle Kameka; Fenella J Kirkham; Harvey Luksenburg; Shirley Miller; Patricia Ann Oneal; David C Rees; Rosanna Setse; Vivien A Sheehan; John Strouse; Cheryl L Stucky; Ellen M Werner; John C Wood; William T Zempsky
Journal:  Blood Adv       Date:  2019-12-10

Review 10.  Spinal and afferent PKC signaling mechanisms that mediate chronic pain in sickle cell disease.

Authors:  Ying He; Zaijie Jim Wang
Journal:  Neurosci Lett       Date:  2019-04-30       Impact factor: 3.046

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.